文献速递骨质疏松与代谢性骨病

瑞典老年女性骨质疏松症治疗严重不足

Extensive undertreatment of osteoporosis in older Swedish women.
PubMed 文献 · Osteoporos Int · 2019-02-25

一项在瑞典哥德堡开展的基于人群的研究纳入3028名老年女性(平均年龄77.8±1.6岁),依据瑞典骨质疏松学会(SvOS)指南评估治疗资格。在数据完整的2983名女性中,1107名(37%)符合治疗标准,但其中仅21.8%接受了骨质疏松药物治疗。

要点

  • 在符合SvOS治疗标准的老年女性中,仅21.8%接受了骨质疏松药物治疗。
  • 符合治疗标准者中,糖皮质激素治疗(OR 2.88,95%CI 1.80-4.59)和既往骨折(OR 2.58,95%CI 1.84-3.61)是接受治疗的强预测因素。
  • 数据完整的2983名女性中,1107名(37%)符合SvOS治疗标准。

核心结论

  • 研究显示,相当比例的瑞典老年女性因骨折高风险应考虑接受骨质疏松药物治疗,但仅少数接受了治疗。

研究设计与样本

  • 在哥德堡开展的基于人群的研究,纳入3028名老年女性(平均年龄77.8±1.6岁)。
  • 采用双能X线吸收法测量脊柱和髋部骨密度,通过自填问卷收集骨折临床危险因素和骨质疏松药物使用数据。
  • 采用Logistic回归评估10年主要骨质疏松性骨折概率(FRAX评分)或其组成部分是否预测骨质疏松药物治疗。

主要发现

  • 数据完整的2983名女性中,1107名(37%)符合SvOS治疗标准。
  • 符合SvOS治疗标准的女性中,接受治疗的比例为21.8%。
  • 符合SvOS治疗标准者中,接受骨质疏松药物治疗的强预测因素为糖皮质激素治疗(OR 2.88,95%CI 1.80-4.59)和既往骨折(OR 2.58,95%CI 1.84-3.61)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In a population-based study of older Swedish women, we investigated the proportion of women treated with osteoporosis medication in relation to the proportion of women eligible for treatment according to national guidelines. We found that only a minority (22%) of those eligible for treatment were prescribed osteoporosis medication. INTRODUCTION: Fracture rates increase markedly in old age and the incidence of hip fracture in Swedish women is among the highest in the world. Although effective pharmacological treatment is available, treatment rates remain low. Limited data are available regarding treatment rates in relation to fracture risk in a population-based setting in older women. Therefore, we aimed to investigate the proportion of older women eligible for treatment according to Swedish Osteoporosis Society (SvOS) guidelines. METHODS: A population-based study was performed in Gothenburg in 3028 older women (77.8 ± 1.6 years [mean ± SD]). Bone mineral density of the spine and hip was measured with dual-energy X-ray absorptiometry. Clinical risk factors for fracture and data regarding osteoporosis medication was collected with self-administered questionnaires. Logistic regression was used to evaluate whether the 10-year probability of sustaining a major osteoporotic fracture (FRAX-score) or its components predicted treatment with osteoporosis medication. RESULTS: For the 2983 women with complete data, 1107 (37%) women were eligible for treatment using SvOS criteria. The proportion of these women receiving treatment was 21.8%. For women eligible for treatment according to SvOS guidelines, strong predictors for receiving osteoporosis medication were glucocorticoid treatment (odds ratio (95% CI) 2.88 (1.80-4.59)) and prior fracture (2.58 (1.84-3.61)). CONCLUSION: This study demonstrates that a substantial proportion of older Swedish women should be considered for osteoporosis medication given their high fracture risk, but that only a minority receives treatment.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Lorentzon M, Nilsson AG, Johansson H, et al. Extensive undertreatment of osteoporosis in older Swedish women. Osteoporos Int. 2019. PMID: 30805678. doi:10.1007/s00198-019-04872-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。